Adrian Hackett

Adrian Hackett is an experienced professional in the field of preclinical toxicology and nonclinical development. Currently serving as Associate Director of Preclinical Toxicology at Actinium Pharmaceuticals, Inc. since October 2022, Adrian previously held the position of Associate Director, Nonclinical Development at Kadmon from September 2019 to October 2022. Prior to that, Adrian spent over a decade at PsychoGenics in various roles including Sr. Research Associate and Associate Scientist, where responsibilities included coordinating studies and drafting standard operating procedures. Earlier experience includes working as an Assistant Scientist at Sanofi, overseeing long-term oncology studies, and as a Laboratory Assistant at Rutgers University, focusing on animal husbandry and oncology research. Adrian holds a Bachelor's degree in Animal Sciences with a minor in Environmental and Business Economics from Rutgers University.